← FDA Drug Approvals (Drugs@FDA)
ATAZANAVIR SULFATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN · Approved 2018-09-24
Drug application
- FDA Application #
ANDA208177- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ATAZANAVIR SULFATE
- Generic name
- Atazanavir Sulfate
- Active ingredients
- ATAZANAVIR SULFATE
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- MYLAN
- First approval
- 2018-09-24
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown